These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1775978)

  • 41. Molecular interrelationships in multidrug resistance (review).
    Kellen JA
    Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer chemotherapy.
    Carter SK
    Front Radiat Ther Oncol; 1980; 15():58-65. PubMed ID: 7239187
    [No Abstract]   [Full Text] [Related]  

  • 43. Will there be a future role for radiation in the neo-adjuvant therapy for rectal cancer?
    Mohiuddin M; Thomas CR
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):643-4. PubMed ID: 21621118
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemotherapy in advanced bladder cancer: a review with emphasis on future studies.
    Splinter TA
    Arch Esp Urol; 1990; 43 Suppl 2():215-7. PubMed ID: 2096782
    [No Abstract]   [Full Text] [Related]  

  • 45. Improved adjuvant chemotherapy for cancer.
    Knock FE
    Surg Gynecol Obstet; 1966 May; 122(5):991-1002. PubMed ID: 5948982
    [No Abstract]   [Full Text] [Related]  

  • 46. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
    Hofsli E
    Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mechanism of multidrug resistance in human cancers].
    Zhang HY
    Sheng Li Ke Xue Jin Zhan; 1992 Jan; 23(1):30-5. PubMed ID: 1411422
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings: The future of cancer chemotherapy.
    Burchenal JH
    Proc Natl Cancer Conf; 1972; 7():123-30. PubMed ID: 4764894
    [No Abstract]   [Full Text] [Related]  

  • 50. Tumor cell drug resistance and its reversal.
    Mansouri A; Henle KJ; Nagle WA; Moss AJ
    SAAS Bull Biochem Biotechnol; 1990 Jan; 3():91-6. PubMed ID: 1366508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current emphasis in experimental cancer research and its relation to clinical oncology].
    Seeber S
    Onkologie; 1986 Oct; 9 Suppl 2():14, 17-9. PubMed ID: 3534669
    [No Abstract]   [Full Text] [Related]  

  • 52. [Rationalization of adjuvant chemotherapy by induction chemotherapy].
    Hoerni B; Chauvergne J
    Bull Cancer; 1984; 71(4):297-300. PubMed ID: 6498345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advances in drug therapy of neoplasms].
    Gross R
    Verh Dtsch Ges Inn Med; 1972; 78():93-105. PubMed ID: 4665784
    [No Abstract]   [Full Text] [Related]  

  • 54. Carcinogenesis and the response of tumours to anticancer drugs.
    Keith WN; Brown R
    Anticancer Res; 1991; 11(5):1739-43. PubMed ID: 1768046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Resistance to chemotherapeutic agents in the treatment of cancer. Emphasizing the multiresistant phenotype].
    Holte H
    Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2423-7. PubMed ID: 1926080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic and kinetic factors in the drug resistance of micrometastatic disease.
    Goldie JH
    Prog Clin Biol Res; 1990; 354A():99-107. PubMed ID: 2247503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review.
    Biedler JL; Spengler BA; Ross RA
    Prog Clin Biol Res; 1990; 354A():287-312. PubMed ID: 2247493
    [No Abstract]   [Full Text] [Related]  

  • 58. [Oncobiogram and its significance in the choice and efficacy of cytostatic therapy].
    Savran VR
    Vopr Onkol; 1983; 29(3):106-13. PubMed ID: 6340347
    [No Abstract]   [Full Text] [Related]  

  • 59. [Drug resistance and implication for therapy].
    Tsuruo T
    Rinsho Ketsueki; 1989 Aug; 30(8):1128-32. PubMed ID: 2574754
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Perspectives on modulation of chemoresistance of malignant diseases].
    Allerödder HP; Ukena D; Sybrecht GW
    Pneumologie; 1993 Sep; 47(9):513-7. PubMed ID: 7901849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.